Coexpressed RIG-I agonist enhances humoral immune response to influenza virus DNA vaccine

Journal of Virology

Volumn 85, Issue 3, 2011, Pages 1370-1383

  Luke, Jeremy M ^a   Simon, Gregory G ^b   Söderholm, Jonas ^c,e   Errett, John S ^d   August, J Thomas ^b   Gale Jr , Michael ^d   Hodgson, Clague P ^a   Williams, James A ^a  

^a NATURE TECHNOLOGY CORPORATION   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Inovio Biomedical Corporation   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; DNA DIRECTED RNA POLYMERASE III; DNA VACCINE; DOUBLE STRANDED RNA; ERNA 11F LIGAND; ERNA 18 LIGAND; ERNA 41H LIGAND; ERNA 45 LIGAND; ERNA DSU6 H1 LIGAND; ERNA VA1 LIGAND; ERNA11A LIGAND; ERNA11D LIGAND; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; INTERFERON; INTERFERON PROMOTER STIMULATOR 1; NAKED DNA; PLASMID VECTOR; PROTEIN; RETINOIC ACID INDUCIBLE PROTEIN I; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN BINDING; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA TRANSCRIPTION; DRUG POTENCY; EMBRYO; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNOSTIMULATION; INFLUENZA VACCINATION; INFLUENZA VIRUS A H5N1; INNATE IMMUNITY; INTERFERON PRODUCTION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE; ANIMALS; ANTIBODIES, VIRAL; DEAD-BOX RNA HELICASES; HEMAGGLUTININS, VIRAL; IMMUNITY, HUMORAL; IMMUNIZATION, SECONDARY; INFLUENZA VACCINES; INJECTIONS, INTRAMUSCULAR; INTERFERON TYPE I; MICE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NUCLEIC ACID CONFORMATION; RNA, DOUBLE-STRANDED; VACCINES, DNA;

ADENOVIRIDAE; IPS; MUS; ORTHOMYXOVIRIDAE;

EID: 78651410969     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01250-10     Document Type: Article

References (76)

1. Andersson, M. G., et al. 2005. Suppression of RNA interference by adenovirus virus-associated RNA. J. Virol. 79:9556-9565.
2. Arruda, L. B., et al. 2006. Dendritic cell-lysosomal-associated membrane protein (LAMP) and LAMP-1-HIV-1 gag chimeras have distinct cellular trafficking pathways and prime T and B cell responses to a diverse repertoire of epitopes. J. Immunol. 177:2265-2275.
3. Barber, M. R., J. R. Aldridge, R. G. Webster, and K. E. Magor. 2010. Association of RIG-I with innate immunity of ducks to influenza. Proc. Natl. Acad. Sci. U. S. A. 107:5913-5918.
4. Barchet, W., V. Wimmenauer, M. Schlee, and G. Hartmann. 2008. Accessing the therapeutic potential of immunostimulatory nucleic acids. Curr. Opin. Immunol. 20:389-395.
5. Besch, R., et al. 2009. Proapoptotic signaling induced by RIG-I and MDA-5 results in type I interferon-independent apoptosis in human melanoma cells. J. Clin. Invest. 119:2399-2411.
6. Biacchesi, S., et al. 2009. Mitochondrial antiviral signaling protein plays a major role in induction of the fish innate immune response against RNA and DNA viruses. J. Virol. 83:7815-7827.
7. Bitro, V., A. Musiyenko, M. A. Bayfield, R. J. Maraia, and S. Barik. 2008. Cellular La protein shields nonsegmented negative-strand RNA viral leader RNA from RIG-I and enhances virus growth by diverse mechanisms. J. Virol. 82:7977-7987.
8. Bramson, J. L., et al. 2003. Super-activated interferon-regulatory factors can enhance plasmid immunization. Vaccine 21:1363-1370.
9. Cao, X. 2009. New DNA-sensing pathway feeds RIG-I with RNA. Nat. Immunol. 10:1049-1051.
10. Desai, S. Y., et al. 1995. Activation of interferon-inducible 2′-5′ oligoadenylate synthetase by adenoviral VAI RNA. J. Biol. Chem. 270:3454-3461.
11. Fang, J., S. Bredow, P. Taishi, J. A. Majde, and J. M. Krueger. 1999. Synthetic influenza viral double-stranded RNA induces an acute-phase response in rabbits. J. Med. Virol. 57:198-203.
12. Fejer, G., et al. 2008. Key role of splenic myeloid DCs in the IFN-alphabeta response to adenoviruses in vivo. PLoS Pathog. 4:e1000208.
13. Gwizdek, C., et al. 2003. Exportin-5 mediates nuclear export of minihelix-containing RNAs. J. Biol. Chem. 278:5505-5508.
14. Hornung, V., et al. 2006. 5′-Triphosphate RNA is the ligand for RIG-I. Science 314:994-997.
15. Hornung, V., and E. Latz. 2010. Intracellular DNA recognition. Nat. Rev. Immunol. 10:123-130.
16. Ishii, K. J., et al. 2008. TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines. Nature 451:725-729.
17. Jechlinger, W. 2006. Optimization and delivery of plasmid DNA for vaccination. Expert Rev. Vaccines 5:803-825.
18. Kobiyama, K., et al. 2009. A signaling polypeptide derived from an innate immune adaptor molecule can be harnessed as a new class of vaccine adjuvant. J. Immunol. 182:1593-1601.
19. Köhler, A., and E. Hurt. 2007. Exporting RNA from the nucleus to the cytoplasm. Nat. Rev. Mol. Cell Biol. 8:761-773.
20. Koyama, S., et al. 2009. Innate immune control of nucleic acid-based vaccine immunogenicity. Expert Rev. Vaccines 8:1099-1107.
21. Kumagai, Y., O. Takeuchi, and S. Akira. 2008. Pathogen recognition by innate receptors. J. Infect. Chemother. 14:86-92.
22. Kumagai, Y., O. Takeuchi, and S. Akira. 2008. TLR9 as a key receptor for the recognition of DNA. Adv. Drug Deliv. Rev. 60:795-804.
23. Kumar, H., T. Kawai, and S. Akira. 2009. Pathogen recognition in the innate immune response. Biochem. J. 420:1-16.
24. Kumar, H., S. Koyama, K. J. Ishii, T. Kawai, and S. Akira. 2008. Cutting edge: cooperation of IPS-1 and TRIF-dependent pathways in poly IC-enhanced antibody production and cytotoxic T cell responses. J. Immunol. 180:683-687.
25. Kuwabara, T., et al. 2001. Significantly higher activity of a cytoplasmic hammerhead ribozyme than a corresponding nuclear counterpart: engineered tRNAs with an extended 3′ end can be exported efficiently and specifically to the cytoplasm in mammalian cells. Nucleic Acids Res. 29:2780-2788.
26. Lahira, A., P. Das, and D. Chakravortty. 2008. Engagement of TLR signaling as adjuvant: towards smarter vaccine and beyond. Vaccine 26:6777-6783.
27. Lamb, R. A., and P. W. Choppin. 1983. The gene structure and replication of influenza virus. Annu. Rev. Biochem. 52:467-506.
28. Lei, M., Y. Liu, and C. E. Samuel. 1998. Adenovirus VAI RNA antagonizes the RNA-editing activity of the ADAR adenosine deaminase. Virology 245:188-196.
29. Li, D., et al. 2007. Adjuvant effects of plasmid-generated hairpin RNA molecules on DNA vaccination. Vaccine 25:6992-7000.
30. Li, J., R. Kjeken, I. Mathiesen, and D. H. Barouch. 2008. Recruitment of antigen-presenting cells to the site of inoculation and augmentation of human immunodeficiency virus type 1 DNA vaccine immunogenicity by in vivo electroporation. J. Virol. 82:5643-5649.
31. Lu, S., and B. R. Cullen. 2004. Adenovirus VA1 Noncoding RNA can inhibit small interfering RNA and microRNA biogenesis. J. Virol. 78:12868-12876.
32. Luke, J., A. E. Carnes, C. P. Hodgson, and J. A. Williams. 2009. Improved antibiotic-free DNA vaccine vectors utilizing a novel RNA based plasmid selection system. Vaccine 27:6454-6559.
33. Ma, Y., and M. B. Mathews. 1993. Comparative analysis of the structure and function of adenovirus virus-associated RNAs. J. Virol. 67:6605-6617.
34. Ma, Y., and M. B. Mathews. 1996. Secondary and tertiary structure in the central domain of adenovirus type 2 VA RNAI. RNA 2:937-951.
35. Marques, J. T., et al. 2006. A structural basis for discriminating between self and nonself double-stranded RNAs in mammalian cells. Nat. Biotechnol. 24:559-565.
36. Mathews, M. B., and A. M. Francoeur. 1984. La antigen recognizes and binds to the 3′ oligouridylate tail of a small RNA. Mol. Cell. Biol. 4:1134-1140.
37. Melchjorsen, J., et al. 2005. Activation of innate defense against a paramyxovirus is mediated by RIG-I and TLR7 and TLR8 in a cell-type-specific manner. J. Virol. 79:12944-12951.
38. Mestas, J., and C. C. W. Hughes. 2004. Of mice and not men: differences between mouse and human immunology. J. Immunol. 172:2731-2738.
39. Mibayashi, M., et al. 2007. Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus. J. Virol. 81:514-524.
40. Muruve, D. A., et al. 2008. The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response. Nature 452:103-107.
41. Nociari, M., O. Ocheretina, J. W. Schoggins, and E. Falck-Pedersen. 2007. Sensing infection by adenovirus: Toll-like receptor-independent viral DNA recognition signals activation of the interferon regulatory factor 3 master regulator. J. Virol. 81:4145-4157.
42. Okada, C., et al. 2009. A high-resolution structure of the pre-microRNA nuclear export machinery. Science 326:1275-1279.
43. Pichlmair, A., et al. 2006. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science 314:997-1001.
44. Pichlmair, A., et al. 2009. Activation of MDA5 requires higher-order RNA structures generated during virus infection. J. Virol. 83:10761-10769.
45. Plumet, S., et al. 2007. Cytosolic 5′-triphosphate ended viral leader transcript of measles virus as activator of the RIG I-mediated interferon response. PLoS 2:e279.
46. Poeck, H., et al. 2008. 5′-Triphosphate-siRNA: turning gene silencing and RIG-I activation against melanoma. Nat. Med. 14:1256-1263.
47. Poeck, H., et al. 2010. Recognition of RNA virus by RIG-I results in activation of CARD9 and inflammasome signaling for interleukin 1 beta production. Nat. Immunol. 11:63-69.
48. Pullen, G. R., M. G. Fitzgerald, and C. S. Hosking. 1986. Antibody avidity determination by ELISA using thiocyanate elution. J. Immunol. Methods 86:83-87.
49. Rahman, A., P. Malhotra, R. Dhar, T. Kewalramani, and B. Thimmapaya. 1995. Effect of single-base substitutions in the central domain of virus-associated RNA I on its function. J. Virol. 69:4299-4307.
50. Samanta, M., D. Iwakira, T. Kanda, T. Imaizumi, and K. Takada. 2006. EB virus-encoded RNAs are recognized by RIG-I and activate signaling to induce type I IFN. EMBO J. 25:4207-4214.
51. Sasaki, S., R. R. Amara, W. S. Yeow, P. M. Pitha, and H. L. Robinson. 2002. Regulation of DNA-raised immune responses by cotransfected interferon-regulatory factors. J. Virol. 76:6652-6659.
52. Schlee, M., et al. 2009. Recognition of 5′ triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus. Immunity 31:25-34.
53. Shirota, H., L. Petrenko, T. Hattori, and D. M. Klinman. 2009. Contribution of IRF-3 mediated IFN-β production to DNA vaccine dependent cellular immune responses. Vaccine 27:2144-2149.
54. Singh, R., S. Gupta, and R. Reddy. 1990. Capping of mammalian U6 small nuclear RNA in vitro is directed by a conserved stem-loop and AUAUAC sequence: conversion of a noncapped RNA into a capped RNA. Mol. Cell Biol. 10:939-946.
55. Strat, A., et al. 2006. Specific and nontoxic silencing in mammalian cells with expressed long dsRNAs. Nucleic Acids Res. 34:3803-3810.
56. Sumpter, R., et al. 2005. Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. J. Virol. 79:2689-2699.
57. Suthar, M. S., et al. 2010. IPS-1 is essential for the control of West Nile virus infection and immunity. PLoS Pathog. 6:e1000757.
58. Unterholzner, L., et al. 2010. IFI16 is an innate immune sensor for intracellular DNA. Nat. Immunol. 11:997-1104.
59. Vaine, M., S. Wang, A. Hackett, J. Arthos, and S. Lu. 2010. Antibody responses elicited through homologous or heterologous prime-boost DNA and protein vaccinations differ in functional activity and avidity. Vaccine 28:2999-3007.
60. Vennström, B., U. Pettersson, and L. Philipson. 1978. Two initiation sites for adenovirus 5.5S RNA. Nucleic Acids Res. 5:195-204.
61. Vitali, P., and A. D. J. Scadden. 2010. Double-stranded RNAs containing multiple IU pairs are sufficient to suppress interferon induction and apoptosis. Nat. Struct. Mol. Biol. 17:1043-1050.
62. Wang, Q., and G. G. Carmichael. 2004. Effect of length and location on the cellular response to double-stranded RNA. Microb. Mol. Biol. Rev. 68:432-452.
63. Wang, W., M. Cella, S. Gilfillan, and M. Colonna. 2010. Cutting edge: polinosinic:polycytidylic acid boosts the generation of memory CD8 cells through melanoma differentiation-associated protein 5 expressed in stromal cells. J. Immunol. 184:2751-2755.
64. Whitmore, M. M., et al. 2004. Synergistic activation of innate immunity by double-stranded RNA and CpG DNA promotes enhanced antitumor activity. Cancer Res. 64:5850-5860.
65. Williams, J. A., A. E. Carnes, and C. P. Hodgson. 2009. Plasmid DNA vaccine vector design: impact on efficacy, safety and upstream production. Biotechnol. Adv. 27:353-370.
66. Williams, J. A., C. P. Hodgson, and A. E. Carnes. 2009. Rapid process development for high yielding plasmid DNA fed-batch fermentation. BioPharm Int. 22(11):46-51.
67. Williams, J. A., J. Luke, L. Johnson, and C. P. Hodgson. 2006. pDNAVACCultra vector family: high throughput intracellular targeting DNA vaccine plasmids. Vaccine 24:4671-4676.
68. Williams, J. A., et al. 2009. Generic plasmid DNA production platform incorporating low metabolic burden seed-stock and fed-batch fermentation processes. Biotechnol. Bioeng. 103:1129-1143.
69. Yoneyama, M., et al. 2004. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5:730-737.
70. Yu, C. Y., R. L. Chiang, T. H. Chang, C. L. Liao, and Y. L. Lin. 2010. The interferon stimulator mitochondrial antiviral signaling protein facilitates cell death by disrupting the mitochondrial membrane potential and by activating caspases. J. Virol. 84:2421-2431.
71. Zeng, Y., and B. R. Cullen. 2004. Structural requirements for pre-microRNA binding and nuclear export by exportin 5. Nucleic Acids Res. 32:4776-4785.
72. Zheng, X., and P. C. Bevilacqua. 2004. Activation of the protein kinase PKR by short double-stranded RNAs with single-stranded tails. RNA 10:1934-1945.
73. Zhu, J., X. Huang, and Y. Yang. 2007. Innate immune response to adenoviral vectors is mediated by both Toll-like receptor-dependent and-independent pathways. J. Virol. 81:3170-3180.
74. Zhu, J., X. Huang, and Y. Yang. 2009. The TLR9-MyD88 pathway is critical for adaptive immune responses to adeno-associated virus gene therapy vectors in mice. J. Clin. Invest. 119:2388-2398.
75. Zou, J., M. Chang, P. Nie, and C. J. Secombes. 2009. Origin and evolution of the RIG-I like RNA helicase gene family. BMC Evol. Biol. 9:85.
76. Zuker, M. 2003. Mfold Web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. 31:3406-3415.